发明申请
- 专利标题： FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS
- 专利标题（中）： 熔融三氯化合物作为新型抑制剂
-
申请号： US13379685申请日： 2010-06-30
-
公开(公告)号： US20120178744A1公开(公告)日： 2012-07-12
- 发明人: Cliff C. Cheng , Hongbo Zeng , Gerald W. Shipps, JR. , Yongqi Deng , Zhaoyang Meng , Lianyun Zhao , Yang Nan , Binyuan Sun , Duan Liu , Panduranga A. Reddy , M. Arshad Siddiqui
- 申请人： Cliff C. Cheng , Hongbo Zeng , Gerald W. Shipps, JR. , Yongqi Deng , Zhaoyang Meng , Lianyun Zhao , Yang Nan , Binyuan Sun , Duan Liu , Panduranga A. Reddy , M. Arshad Siddiqui
- 国际申请： PCT/US2010/040604 WO 20100630
- 主分类号： A61K31/541
- IPC分类号： A61K31/541 ; A61K31/519 ; A61P35/00 ; C07D487/14
摘要：
The present invention provides Fused Tricyclic Compounds of the Formula (I) wherein Q, R1, R2, R3, and R4 are as defined herein, and pharmaceutically acceptable salts of such Fused Tricyclic Compounds. The Fused Tricyclic Compounds are useful in the treatment of cancer and other proliferative disorders.
公开/授权文献
- US08609675B2 Fused Tricyclic Compounds as novel mTOR inhibitors 公开/授权日：2013-12-17
信息查询
